Morningstar Research

Intellia Therapeutics (NTLA) Stock Price Could Touch $85 in Long Term: Morningstar Research

Intellia Therapeutics (NTLA) Stock Price Could Touch $85 in Long Term: Morningstar Research

Morningstar’s recent analysis suggests a "Buy" on Intellia Therapeutics, assigning a fair value of $85 per share, while the current trading price is significantly lower at $15.85.

AutoNation Incorporated (NYSE: AN) Stock Price Could Reach $192: Morningstar Research

AutoNation Incorporated (NYSE: AN) Stock Price Could Reach $192: Morningstar Research

Morningstar recommends a “Buy” on AutoNation Inc. (NYSE: AN) with a fair value estimate of $192 per share.

Sanofi SA (ADR: SNY) Stock Price Could Reach $63: Morningstar Research

Sanofi SA (ADR: SNY) Stock Price Could Reach $63: Morningstar Research

Morningstar has issued a BUY recommendation on Sanofi SA, with an upgraded fair value target of $63 from $61 due to consistent revenue growth and strong performance in immunology and vaccine divisi

Pages